Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 2
2014 1
2016 1
2017 1
2019 1
2020 1
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
A prediction rule for polyarticular extension in oligoarticular-onset juvenile idiopathic arthritis.
Schiappapietra B, Bava C, Rosina S, Pistorio A, Mongelli F, Pederzoli S, Verazza S, Lanni S, Muratore V, Davì S, Dalprà S, Varnier GC, Bertamino M, Suffia C, Bracciolini G, Giancane G, Consolaro A, Ravelli A. Schiappapietra B, et al. Among authors: verazza s. Clin Exp Rheumatol. 2021 Jul-Aug;39(4):913-919. doi: 10.55563/clinexprheumatol/uxnm7j. Epub 2021 May 5. Clin Exp Rheumatol. 2021. PMID: 34001309
Analysis of arthritis flares after achievement of inactive disease with methotrexate monotherapy in juvenile idiopathic arthritis.
Bava C, Mongelli F, Pistorio A, Bertamino M, Bracciolini G, Dalprà S, Davì S, Lanni S, Muratore V, Pederzoli S, Rosina S, Schiappapietra B, Suffia C, Varnier GC, Verazza S, Giancane G, Consolaro A, Ravelli A. Bava C, et al. Among authors: verazza s. Clin Exp Rheumatol. 2021 Mar-Apr;39(2):426-433. doi: 10.55563/clinexprheumatol/rxidz4. Epub 2020 Nov 12. Clin Exp Rheumatol. 2021. PMID: 33200734 Free article.
Parent and child acceptable symptom state in juvenile idiopathic arthritis.
Filocamo G, Consolaro A, Schiappapietra B, Ruperto N, Pistorio A, Solari N, Pederzoli S, Verazza S, Martini A, Ravelli A. Filocamo G, et al. Among authors: verazza s. J Rheumatol. 2012 Apr;39(4):856-63. doi: 10.3899/jrheum.110745. Epub 2012 Feb 1. J Rheumatol. 2012. PMID: 22298905
A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis.
Bava C, Mongelli F, Pistorio A, Bertamino M, Bracciolini G, Dalprà S, Davì S, Lanni S, Muratore V, Pederzoli S, Rosina S, Schiappapietra B, Suffia C, Varnier G, Verazza S, Giancane G, Consolaro A, Ravelli A. Bava C, et al. Among authors: verazza s. Pediatr Rheumatol Online J. 2019 Jul 25;17(1):50. doi: 10.1186/s12969-019-0355-0. Pediatr Rheumatol Online J. 2019. PMID: 31345226 Free PMC article.
Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial.
Ravelli A, Davì S, Bracciolini G, Pistorio A, Consolaro A, van Dijkhuizen EHP, Lattanzi B, Filocamo G, Verazza S, Gerloni V, Gattinara M, Pontikaki I, Insalaco A, De Benedetti F, Civino A, Presta G, Breda L, Marzetti V, Pastore S, Magni-Manzoni S, Maggio MC, Garofalo F, Rigante D, Gattorno M, Malattia C, Picco P, Viola S, Lanni S, Ruperto N, Martini A; Italian Pediatric Rheumatology Study Group. Ravelli A, et al. Among authors: verazza s. Lancet. 2017 Mar 4;389(10072):909-916. doi: 10.1016/S0140-6736(17)30065-X. Epub 2017 Feb 3. Lancet. 2017. PMID: 28162781
Antinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis.
Ravelli A, Varnier GC, Oliveira S, Castell E, Arguedas O, Magnani A, Pistorio A, Ruperto N, Magni-Manzoni S, Galasso R, Lattanzi B, Dalprà S, Battagliese A, Verazza S, Allegra M, Martini A. Ravelli A, et al. Among authors: verazza s. Arthritis Rheum. 2011 Jan;63(1):267-75. doi: 10.1002/art.30076. Arthritis Rheum. 2011. PMID: 20936630 Free article.
Defining criteria for high disease activity in juvenile idiopathic arthritis based on the juvenile arthritis disease activity score.
Consolaro A, Ruperto N, Bracciolini G, Frisina A, Gallo MC, Pistorio A, Verazza S, Negro G, Gerloni V, Goldenstein-Schainberg C, Sztajnbok F, Wulffraat NM, Martini A, Ravelli A; Paediatric Rheumatology International Trials Organization (PRINTO). Consolaro A, et al. Among authors: verazza s. Ann Rheum Dis. 2014 Jul;73(7):1380-3. doi: 10.1136/annrheumdis-2013-204186. Epub 2013 Dec 17. Ann Rheum Dis. 2014. PMID: 24347571
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept.
Verazza S, Davì S, Consolaro A, Bovis F, Insalaco A, Magni-Manzoni S, Nicolai R, Marafon DP, De Benedetti F, Gerloni V, Pontikaki I, Rovelli F, Cimaz R, Marino A, Zulian F, Martini G, Pastore S, Sandrin C, Corona F, Torcoletti M, Conti G, Fede C, Barone P, Cattalini M, Cortis E, Breda L, Olivieri AN, Civino A, Podda R, Rigante D, La Torre F, D'Angelo G, Jorini M, Gallizzi R, Maggio MC, Consolini R, De Fanti A, Muratore V, Alpigiani MG, Ruperto N, Martini A, Ravelli A; Italian Pediatric Rheumatology Study Group. Verazza S, et al. Pediatr Rheumatol Online J. 2016 Dec 20;14(1):68. doi: 10.1186/s12969-016-0126-0. Pediatr Rheumatol Online J. 2016. PMID: 27993144 Free PMC article.